(Q44673201)

English

Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

0 references

Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease (English)

1 reference

Europe PubMed Central

5 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mark T Cahill

1

1 reference

Europe PubMed Central

5 December 2017

Sandra S Stinnett

2

1 reference

Europe PubMed Central

5 December 2017

Sharon Fekrat

3

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

5 December 2017

American Journal of Ophthalmology

1 reference

Europe PubMed Central

5 December 2017

136

1 reference

Europe PubMed Central

5 December 2017

1136-1150

1 reference

Europe PubMed Central

5 December 2017

6

1 reference

Europe PubMed Central

5 December 2017

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia in retinal artery and retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Ocular venous occlusion and hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Ocular venous occlusion and hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma total homocysteine and retinal vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia: a risk factor for central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine: a risk factor for retinal venous occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Thrombophilia as a cause for central and branch retinal artery occlusion in patients without an apparent embolic source

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Thermolabile MTHFR genotype and retinal vascular occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Primary, Secondary, and Meta-Analysis of Research

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Accumulating evidence from independent studies: what we can win and what we can lose

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Methionine metabolism in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Impaired homocysteine metabolism and atherothrombotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Sex-related differences in methionine metabolism and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Gender differences and other determinants of the rise in plasma homocysteine after L-methionine loading

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Effective homocysteine metabolism may protect South African blacks against coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocystinemia. Vascular injury and arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Activation of Hageman Factor by L-Homocystine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

The oxidant stress of hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine induced endothelial damage?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Plasma homocysteine in the acute and convalescent phases after stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Serial measures of plasma homocyst(e)ine after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

An alternative view of homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Trends in serum folate after food fortification.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Familial thrombophilia and retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2803%2900571-3

7 January 2021

Identifiers

10.1016/S0002-9394(03)00571-3

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44673201&oldid=2031303878"